specialized agency of the United Nations. Its work is directed and approved by the World Health Assembly, composed of delegates of the governments of the 90 Member States, and by an Executive Board of 18, nominated by, but not representing, governments.
For greater efficiency, 6 regional offices have been established; the United Kingdom is a member of the European Region. The 1960 budget is approximately 17 million dollars, 1-2 million being devoted to the European Region. Besides the contributions from Member States, other funds are received from the United Nations Expanded Programme of Technical Assistance, from the United Nations Children's Fund (UNICEF), and from the Malaria Eradication Special Account.
WHO and Research
International collaboration is desirable in many research projects, e.g. : (1) Demographic studies, genetic descriptions of populations, disease incidence and prevalence studies, identification of environmental factors causing disease and similar problems of regional or global significance.
(2) Communicable diseases of widespread or world-wide distribution.
(3) Unexplained variations in the incidence and prevalence of disease and in health in widely different environments and under various economic conditions.
(4) Research on rare conditions which require pooling of information to collect together a significant amount of data, the study of which may have wider applications.
(5) Projects requiring special skills in which progress is being delayed because of lack of intercommunication between research workers.
Classical epidemiological techniques can be applied to many of these problems. WHO does not normally undertake research itself but seeks to supplement national research efforts. This it does by: (1) Establishment of reference centres, standardization of methods, reagents, and nomenclature, and provision of other similar services. (2) Training research workers.
(3) Improving intercommunication between research workers. (4) Supporting research by provision of personnel, equipment and grants. (5) Assistance in planning research institutions and programmes.
Valuable results have been obtained by encouraging all staff members, including field staff, to incorporate research work wherever possible in their activities.
Epidemiology
The statistical and epidemiological work of WHO may be considered under four headings:
(1) General activities.-The pattern followed in WHO's epidemiological work is the same as in other fields-the convening of expert committees to study the problem, the holding of seminars to spread information, ad hoc assistance in response to specific requests (WHO only intervenes by invitation of the government concerned) and training in scientific methods by the provision of fellowships and courses.
A task inherited from pre-existing organizations and a prime duty of WHO is to ensure that work carried out in different countries and institutions is comparable. One means to this end has been the publication of the "Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death" (WHO, 1957a). These standards must not only be issued but people have to be induced to use them; even within the United Kingdom the international form of medical certificate of cause of death is not universally used.
Continuity in the study of these problems is provided by a series of meetings of expert committees on health statistics, by the establishment of a WHO Centre for Classification of Diseases 'World Health Organization Regional Office for Europe, Copenhagen, Denmark. in London to which all countries can turn for advice, and by the support given to national committees on vital and health statistics in Member States. It is hoped that eventually mortality reports from different Member States will be comparable; this is a long-term project and comparisons made to-day of the mortality experience of different countries show widely differing standards.
These difficulties apply equally to morbidity figures. WHO tries to establish standardization of procedures and nomenclature in many fields as an essential prelude for comparable epidemiological studies in different countries or even different areas in a single country. It is often found that wide variations can exist between communities in the same country which at first sight might be thought comparable. These local differences are a challenge to epidemiologists and a forewarning of difficulties likely to arise in international studies.
In their sixth report the Expert Committee on Health Statistics (WHO, 1959b) laid down concepts, definitions and terminology for measurement of morbidity and considered their applicability to special studies. The same Committee made recommendations for studying the epidemiology of cancer. Similarly a Study Group on the Classification of Atherosclerotic Lesions (WHO, 1958) attempted to formulate a universally acceptable definition of atherosclerosis and laid down methods of grading and recording the lesions in this disease. The Expert Committee on Cardiovascular Disease and Hypertension in its first report (WHO, 1959a) suggested diagnostic criteria and a system of classification. A final example is provided by the eighth report of the Expert Committee on Mental Health (WHO, 1960) which deals with the epidemiology of mental disorders.
WHO runs an epidemiological intelligence service; governments are required to inform the Organization about quarantinable diseases occurring within their territories. This information is collated and distributed by wireless, telegram and airmail, and is further reported in the Weekly Epidemiological Record. Other mortality and morbidity figures are published monthly in the Epidemiological and Vital Statistics Report. Information on non-quarantinable diseases, e.g. influenza and poliomyelitis, is disseminated whenever their prevalence justifies this. In this connexion WHO collected and issued information on the spread of Asian influenza during the 1957 epidemic. A network of regional and national influenza centres has been set up in more than forty countries and they are linked either with the World Influenza Centre in London or with a similar Influenza Centre for the Americas in Alabama. This system of laboratories is being extended to cover many other diseases of international importance, including intestinal and streptococcal infections and brucellosis. Reference centres for cancer, atherosclerosis and other diseases are being planned.
(2) Special studies.-WHO has initiated a series of special studies on world-wide or regional diseases. The first group is exemplified by the studies of Pollitzer on cholera and on plague which have been published in the Bulletin of the World Health Organization, and subsequently also as WHO monographs (Pollitzer, 1954 (Pollitzer, , 1959 ). An example of work done on a regional basis is the group of surveys carried out to detect bilharziasis in a number of countries in south-west Asia and parts of Africa.
A special venture in this field, the Group Report on "Accidents in Childhood; Facts as a basis for Prevention" (WHO, 1 957b), was a first major attempt to examine the epidemiology of accidents from an international point of view. The Group collected and reviewed many epidemiological studies and tabulated this data. It studied the available mortality figures and stressed the need for morbidity figures as well, including figures of "near accidents," so that information on accident risks, probabilities, rates and so on could be deduced. It enumerated the principles for designing sample surveys of the population and a plan for collecting information on accidents which would serve as a basis for accident prevention.
(3) Epidemiological work in disease control activities.-Large-scale programmes have been organized in many countries, often in collaboration with UNICEF, to assist governments in the control of communicable diseases such as malaria, tuberculosis, yaws and trachoma. Much research has been carried out in connexion with these projects and considerable epidemiological information obtained.
In the case of tuberculosis, this research was furthered by the establishment in 1949 of a special Tuberculosis Research Office (T.R.O.) and the examples given below are by-products of mass BCG vaccination projects.
By mid-1959 over 265 million tuberculin tests had been carried out all over the world under the auspices first of the International Tuberculosis Campaign and later of WHO and UNICEF.
The great majority were intradermal Mantoux tests made with a measured dose of standardized Danish tuberculin. Thie largest transverse diameter of skin induration was measured with a ruler after three to four days by trained staff.
Routine field work was directed and evaluated by the T.R.O. and by specially trained field assessment teams. While these millions of tests Section of Epidemiology and Preventive Medicine were probably not all accurately standardized, at any rate by following a standard routine their performance could be checked by the assessment teams and the causes of anomalies could be investigated, including the extent of "observer error". These studies would have been impossible if the different tests in common use had been used indiscriminately.
Certain important practical facts emerged concerning the use of tuberculin in the Mantoux test. Not only do different batches of purified protein derivative (PPD) give somewhat different results, but any particular tuberculin will lose its potency if exposed to heat or sunlight or even if kept in incompletely filled bottles when it is adsorbed to the container to a varying degree (Guld et al., 1955; Magnus et al., 1956) .
The main achievement was obtaining comparable information on tuberculin sensitivity on a world-wide scale, something which had never been done before. This included a large amount of new information about "low grade" tuberculin sensitivity, first described by Carroll Palmer and his associates in the 1940s and recently summarized by Edwards et al. (1959) . The appointment of Palmer to the T.R.O. afforded an opportunity to study this phenomenon intensively on a global scale. Palmer et al. (1959) have produced strong evidence that in U.S.A. low-grade sensitivity is due to infection with mycobacteria other than M. tuberculosis. Whatever the cause, its presence greatly complicates a BCG vaccination campaign. If histograms are constructed, grouping individuals according to size of reaction, in a country like Mexico where lowgrade reactions are uncommon, there are two clearly defined groups: non-reactors and strong reactors. The reactions in the latter group are comparable in size with the reactions seen in known cases of tuberculosis (WHO/T. R.O., 1955) . In a country like the Sudan where lowgrade sensitivity is common, there is no clear distinction between these two groups and it becomes impossible, by means of a simple Mantoux test, to separate clearly the noninfected children who should be vaccinated from those infected who should not.
It has been shown in the United Kingdom that low-grade tuberculin sensitivity may be associated with some degree of immunity against tuberculous disease. It is uncertain to what extent it affects the development of immunity following BCG vaccination (Medical Research Council, 1959) .
In 1954 the Government of the Sudan asked WHO to make a tuberculin survey to determine whether a mass BCG campaign was needed and, if so, how it could best be carried out. The survey, which was a joint effort by WHO UNICEF and the Government was made over a twelve-month period by a specially trained team under the technical direction of the T.R.O. 281 groups selected at random, scattered throughout the country, were examined, including the population of 47 villages, children from 192 schools and members of urban groups, such as police, students, &c. The testing in schools and groups was relatively c-omplete: on an average 91 % of the persons in these groups were tuberculin tested and the test was read. Little is known about the village populations but in the few instances where the size of the population could be estimated about 70% were tested. Standard Mantoux techniques were used, giving 5 I.U. using a Danish PPD. In the survey 56,000 people were tested and 26,000 were given BCG. The total population of the Sudan is estimated at 10 million.
Owing to the prevalence of low-grade sensitivity it proved difficult to decide the size of reaction separating infected from non-infected children. It is known that in Sudan, as elsewhere in the world, the sizes of Mantoux reactions in tuberculous patients are symmetrically distributed round a maximum of 16-18 mm (WHO/ T. R.O., 1955) . On this basis an attempt can be made to estimate the number of children infected with tuberculosis. In deciding which children to vaccinate, it is necessary to weigh the importance of vaccinating as many uninfected children as possible against the desirability of keeping vaccination of the infected to a minimum and eventually an arbitrary decision must be made.
The Government was advised that the prevalence of tuberculosis was high, that a general BCG campaign was justified and that the "negative-positive" level was difficult to estimate but for the purposes of a campaign 7 mm might be appropriate. Incidentally, 5,000 additional tests were carried out with histoplasmin; in two areas only was a significant number of positive tests found so this infection was obviously rare.
(4) Co-ordinated international research.-Consideration is currently being given to the coordination of studies undertaken by a number of research groups on the outcome of pregnancies in the United Kingdom and other European countries; it is probable that this study will be extended to other regions. In 1953 and in 1956 the WHO Regional Office for Europe convened meetings to consider aspects of perinatal mortality and morbidity. The 1956 meeting laid down a series of agreed definitions and a scheme for the studies to be used by the group. This included obstetrical, clinical,-pathological and some social data, but since events during the perinatal period are frequently caused by environmental factors occurring during the early period of gestation, the idea of an internationally co-ordinated prospective study arose. In 1958 contact was established with the National Institutes of Research in the United States which were planning a similar study. A WHO consultant visited a number of groups in the European Region and also saw the work in the United States, and as a result a new meeting was held in December 1959 in Copenhagen, attended by representatives of groups already working in this field who will probably take part in the coordinated studies.
The primary objective of the study is to record events during pregnancy and parturition and correlate these with defects in the foetus. It is clear that as defects are relatively infrequent a large number of pregnancies will have to be studied. It therefore seems to be a project well suited for international co-ordination.
Another series of studies is designed to investigate the differences in cardiovascular mortality reported by various European countries. There may be real differences in the amount of cardiovascular disease and of arteriosclerosis in the population and hence in the mortality from these diseases; on the other hand they may simply be due to discrepancies in terminology, in diagnostic customs or in coding procedures.
A consultant was appointed in August 1958 to investigate the second possibility, i.e. whether these differences are statistical artifacts. This study will be made at first in Denmark, England and Wales, Finland, France, the German Federal Republic and Scotland. These countries have been selected to cover a wide range of reported death rates from cardiovascular disease.
It was decided, to begin with, to compare coding practices in these countries using the method of coding in England and Wales as a standard and for this we are very grateful to the Registrar-General. The study is limited to death certificates of men and women between 45 and 64 years of age, but within that age range it covers all deaths. In this way it is hoped to include a maximum amount of cardiovascular disease, to get a complete picture of coding practices for all diagnoses and combinations of diagnoses and at the same time to avoid the complications of multiple causes of death in old people.
To get a clearer picture further complementary studies will be necessary, including a series of national studies on the reliability of diagnoses entered on death certificates. In particular it is proposed to carry out a series of morbidity and autopsy studies on the prevalence of cardiovascular disease in several countries in the Region. For the autopsy studies there is a guide laid down by the Study Group on the Classification of Atherosclerotic Lesions, but there are two considerable difficulties in the way. The first is the problem of obtaining comparable autopsy samples in different countries. The second is to assess the observer error if the study is carried out by independent investigators, since if a single reference centre is designated there may be legal difficulties in sending relatively intact specimens from one country to another. It is hoped that these difficulties will be resolved during 1960. In the meantime WHO is proceeding with plans to establish a network of centres for pathological studies of atherosclerosis. In this Regional Office we have been for some time studying a plan for a small series of national prevalence surveys to be co-ordinated by WHO. We hope that planning will be completed within the next few months and that a small pilot study will be started this year.
Another topic studied has been atmospheric pollution and WHO is now considering the reports of two consultants who have been visiting research centres in Europe and it seems likely that the Organization will be asked to assist in co-ordinating these studies as well.
Conclusion.-This survey of WHO's work in epidemiology has had to be both brief and selective. I hope that it will nevertheless serve as an introduction to the many important activities of WHO in this field.
